Bioiberica & Heparin

A perfect match

Since its foundation in 1975, Bioiberica has been focused on the production of heparin. The company understood that it was an active ingredient indispensable for human health andthat it was important to be able to offer the maximum guarantees of safety and traceability. Today, one out of every five heparin doses administered worldwide has been developed and manufactured by Bioiberica.

Heparin: a lifesaving molecule 

  • Heparin is the most commonly used anticoagulant in the prevention and treatment of thrombosis. One out of every four people in the world die due to causes related with this disease.
  • It is on the World Health Organisation’s list of essential medicines and it saves more than 100 million lives every year.
  • It has a solid scientific basis and its efficacy and safety have been extensively proven.
  • Although it is a centenary molecule, new applications related with antitumoral, anti inflammatory and antiviral activity are being studied. 

Director of the Heparin Business Unit at Bioibérica 

We talked to Joan Bassa, director of the Heparin Business Unit at Bioibérica, to understand how important is heparin for the company.

Head of research and development at the Heparin Business Unit at Bioibérica

We talked to the head of research and development at the Heparin Business Unit at Bioibérica, Carlos Raul Aláez, to learn more about heparin and its uses.




E-mail address:
Telephone number:
+34 93 490 49 08
+34 93 490 97 11